Barinthus Biotherapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 0 | 0% |
Individual Insiders | 2,680,500 | 6.89% |
General Public | 8,818,703 | 22.7% |
Institutions | 9,826,469 | 25.2% |
VC/PE Firms | 17,595,540 | 45.2% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
17,595,540 | US$36.1m | 29.1% | no data | |||
5,197,349 | US$10.7m | 0% | 0.03% | |||
2,486,754 | US$5.1m | 100% | no data | |||
1,513,644 | US$3.1m | 0% | 0.33% | |||
1,420,473 | US$2.9m | 0% | 0.24% | |||
642,204 | US$1.3m | 0% | 1.51% | |||
542,673 | US$1.1m | 0% | 0.32% | |||
196,296 | US$402.4k | 0% | no data | |||
107,968 | US$221.3k | 0% | 0.01% | |||
107,914 | US$221.2k | 0% | 0.02% | |||
104,209 | US$213.6k | 0% | no data | |||
48,256 | US$98.9k | 0% | no data | |||
29,699 | US$60.9k | 38.8% | no data | |||
23,075 | US$47.3k | 0% | 0.01% | |||
23,000 | US$47.1k | 0% | no data | |||
16,467 | US$33.8k | -22.4% | no data | |||
15,008 | US$30.8k | 0% | no data | |||
11,568 | US$23.7k | 46.8% | no data | |||
10,506 | US$21.5k | 0% | no data | |||
3,000 | US$6.2k | 0% | no data | |||
3,000 | US$6.2k | 0% | no data | |||
1,700 | US$3.5k | 0% | no data | |||
1,547 | US$3.2k | 1,640% | no data | |||
420 | US$861.7 | 0% | no data | |||
104 | US$215.4 | 0% | no data |